Cannabidiol oral solution 200mg/mL

Cannabidiol oral solution 200mg/mL
Product Description

Product description:

  • Commercial name: Myalo
  • Indication: Refractory epilepsy
  • THC FREE
  • Clinical studies phase III - https://clinicaltrials.gov/ct2/show/NCT02783092?term=prati&rank=1
  • Pharmaceutical grade
  • No interconversion "in vivo" THC
  • Oral solution for dose flexibility
  • Proven therapeutic efficacy and safety
  • Concentration: 200 mg/mL
  • Ingredients: Cannabidiol, inert excipients, pharma grade
  • Usage: Oral use
  • Package: Glass bottle, 30 mL - with oral doser
  • Storage: Keep it well closed in room temperature
  • Shelf life: 24 months

Read more Show less

Prati, Donaduzzi & Cia Ltda

  • Country/Region:
    Brazil
  • On CPHI since:
    2019
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    13956-29-1
  • Supplied from
    Brazil
More specifications Fewer specifications

Prati, Donaduzzi & Cia Ltda

  • Country/Region:
    Brazil
  • On CPHI since:
    2019
View company profile

More Products from Prati, Donaduzzi & Cia Ltda (2)

  • Cannabidiol

    Product Cannabidiol

    Pharma Grade Cannabidiol API • Produced by chemical synthesis; • Quality attributes, residual solvents and elemental impurities and in accordance with the ICH guidelines; • Organic impurities (including delta-9-THC and delta-8-THC) bellow to 0.06% (complies fo...
  • CBD

    Product CBD

    Pharma Grade CBD API • Produced by chemical synthesis; • Quality attributes, residual solvents and elemental impurities and in accordance with the ICH guidelines; • Organic impurities (including delta-9-THC and delta-8-THC) bellow to 0.06% (complies for 1750 m...